All of these weight loss medications fall under the pharmaceutical umbrella of Glucagon-like Peptide 1 (GLP-1) receptor ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

As demand for GLP-1 medications surges, Hydreight’s inclusion of Liraglutide introduces a stable, patent-free, and clinically proven option—ideal for patients and providers seeking consistent ...

The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

The following is a summary of “Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and ...

Global guidelines recommend a holistic approach for Type 2 Diabetes Mellitus management by addressing the associated comorbidities. Here, we have conducted a post-hoc evaluation of a Liraglutide ...

Meitheal has launched liraglutide injection (18mg/3mL) in a three-pack and expects to bring additional pack sizes to market later this year. "We are pleased to be launching and bringing ...